Following sector rotations as the economy "slows down" we have finance, healthcare and utilities up next to show strength in the market. With record CPI reported today, it is expected for Feds to raise 75bps next two meetings but the market may begin to price in a 100bps raise given the higher than estimated numbers.
$CRSP is coming out of a wedge and has been...
Chart request for @HHSPN
CRSP had gone oversold on the weekly and deeper than before so a big bounce may be on the cards.
However it doesn't look good that its fallen below this long term demand trendline.
I think what this show is that CRSP has hit its high for now and although it may have a good bounce it will likely drift back and forth across the...
CRSP has likely been bottomed out after long downtrend. I used WTZ4 (Wave to Tunnel) for taking the first profit. Then, another chance occurs. I apply my favorite set up (WTZ2) with expectation of another trend. However, managing your own risks is still recommended. Good Luck!
CRISPR Therapeutics
Short Term
We look to Buy a break of 73.10 (stop at 68.66)
Further upside is expected and we look to set longs in early trade. The trend of higher lows is located at 60.50. Previous resistance, now becomes support at 73.00. A higher correction is expected.
Our profit targets will be 82.99 and 94.00
Resistance: 83.00 / 96.00 /...
CRISPR Therapeutics is a favourite of star stock buyer Cathie Wood. It’s up 27% over the past month. Will this strength last and should I be adding it to my portfolio?
CRISPR Therapeutics (NASDAQ:CRSP) is a Swiss–American biotechnology company headquartered in Zug that uses gene therapy to correct genetic mutations to treat and cure diseases. CRISPR refers to...
CRSP has been consolidating in what is potentially an inverted H&S pattern since hititng inot low on 12 May. Despite the overall market being extremely weak this week, CRSP dipped and quickly recovered forming a potentially bullish candle for this week.
If CRSP can have a weekly close above 68 then there could be grounds for more optimism. However, a weekly close...
As shown, expect submicro wave 2 pullback and then continue to push higher to fair market value. Overall beautiful elliottwave structures and upside expectation remains the same.
CRISPR Therapeutics
Short Term - We look to Buy a break of 59.19 (stop at 54.06)
Further upside is expected and we look to set longs in early trade. A bullish reverse Head and Shoulders has formed. A break of yesterdays high would confirm bullish momentum. A higher correction is expected. Although the anticipated move higher is corrective, it does offer...
Once Again we see a chart at a key area for a nice risk-reward setup.
Personally, I would build a position to the long side here rather than
one-shot it bc the stop is very far away in % terms. Conversely, the
reward, if it starts to run, is very compelling.
why not to double check for assured profit before you pay a dime
Easy line to follow and simple chart be your guide here , it works for a week in #trade
- potential aim for takover (I suppose by VRTX ) . Company has 2.5B in cash, no debt with market cap about 4.5B$ (EV = 2.0 B)
- solid pipeline and probably will be first who get FDA approval for commercial CRISPR product
- got most of up front payment for milestones in CRISPR among competitors ( about 1b$ from Vertex and collaboration with Bayer). BEAM for example...
